Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States of America et al v. Supervalu Inc et al
Case Number:
3:11-cv-03290
Court:
Nature of Suit:
Judge:
Firms
- Goode Casseb
- Helmer Martins
- HeplerBroom
- Hinshaw & Culbertson
- Kirkland & Ellis
- Norton Rose
- Reed Smith
- Robins Kaplan
- Skeen & Kauffman
- Williams & Connolly
Companies
Government Agencies
Sectors & Industries:
-
April 17, 2017
Court Orders Document Production In Pharmacy Price Row
An Illinois federal judge on Monday ordered pharmacy chain Supervalu to produce documents it had been withholding in the discovery phase of the False Claims Act case against it brought by whistleblowers who said the company had misrepresented prices in order to receive higher reimbursement payments from the federal government.
-
October 21, 2016
SuperValu Can't Shed FCA Suit Over Pharmacy Prices
An Illinois federal judge on Friday kept alive a False Claims Act suit accusing SuperValu pharmacies of charging the government more than the general public, finding that lower drug prices could be "usual and customary" regardless of how often they were actually paid.
-
February 17, 2016
SuperValu Drug Pricing Claims Pass FCA Muster, Court Told
Two pharmacists suing SuperValu Inc. in Illinois federal court for allegedly running a nationwide scheme to charge government health care programs more than the general public for prescription drugs on Tuesday said their suit shouldn't be dismissed, as they made sufficient arguments under the False Claims Act.
- ← Previous
- 1
- 2
- Next →